Vivos Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
3.50
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.25
|
-0.26
|
-0.01
|
-4.00%
|
|
2022-06-30
|
-0.25
|
-0.28
|
-0.03
|
-12.00%
|
|
2022-03-31
|
-0.26
|
-0.26
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.25
|
-0.34
|
-0.09
|
-36.00%
|
|
2021-09-30
|
-0.18
|
-0.26
|
-0.08
|
-44.44%
|
|
2021-06-30
|
-0.18
|
-0.19
|
-0.01
|
-5.56%
|
|
2021-03-31
|
-0.17
|
-0.19
|
-0.02
|
-11.76%
|
|
2020-12-31
|
-0.16
|
-0.88
|
-0.72
|
-450.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.80
|
|
2021-12-31
|
-0.98
|
|
2020-12-31
|
-1.45
|
|
2019-12-31
|
-0.67
|
|
2018-12-31
|
-0.23
|